Megafine Pharma P Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Megafine Pharma is engaged in the production of APIs, and advanced intermediates, and offers contract manufacturing services.
One of their notable products is MEMANTINE HYDROCHLORIDE USP, with a corresponding US DMF Number 25402.
Remarkably, this DMF maintains an Active status since its submission on October 14, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 22, 2013, and payment made on April 15, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II